RxDoctor Payments Data

Vikas Sharma

Thoracic Surgery (Cardiothoracic Vascular Surgery) · Salt Lake City, UTNPI 1619282225

Payments from drug & device makers

What this record shows

The money is spread across several categories — travel and lodging (55.8%), education and food and beverage — rather than concentrated in one kind of arrangement. 7 manufacturers reported payments, led by Intuitive Surgical at 44.3% of the total. Reporting peaked in 2021 at $6,363 and has fallen 67.0% since, to $2,099 in 2025.

$13,607in general payments, 2019–2025

Across 54 payments — averaging $251.99 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Intuitive Surgical$6K
  • Edwards Lifesciences$3K
  • Atricure, Inc.$1K
  • Abbott$1K
  • Boston Scientific$1K
  • Artivion, Inc.$619
  • plus $224 from 1 others
$260,035in research payments, 2019–2025

Across 50 payments — averaging $5200.69 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • AbbVie$132K
  • Atricure, Inc.$81K
  • Medtronic$47K

What the payments were for

  • Travel & lodging$7,59556%
  • Food & beverage$1,51211%
  • Education$4,50033%

General payments by program year

19
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
Intuitive Surgical11$6,021
Edwards Lifesciences15$3,314
Atricure, Inc.9$1,368
Abbott10$1,049
Boston Scientific6$1,012
Artivion, Inc.2$619
Medtronic1$224

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$13,607 in reported general payments places this provider in the 75th percentile of 46 thoracic surgery (cardiothoracic vascular surgery) providers in Utah.

See all thoracic surgery (cardiothoracic vascular surgery) providers in Utah

Medicare billing

Part B allowed, 2024
$134,031
Medicare patients
160
Services billed
332

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Metoprolol Succinate13$83

Paid to pharmacies, not to this prescriber.

Other thoracic surgery (cardiothoracic vascular surgery) in Salt Lake City

See the full list for Utah

Where these figures come from

Is this you, or does something look wrong? →